On Tuesday, Candel Therapeutics Inc (NASDAQ: CADL) was 4.61% up from the session before settling in for the closing price of $5.86. A 52-week range for CADL has been $4.25 – $13.68.
Annual sales at Healthcare sector company slipped by -43.86% over the past five years. When this article was written, the company’s average yearly earnings per share was at 75.68%. With a float of $41.06 million, this company’s outstanding shares have now reached $54.90 million.
Candel Therapeutics Inc (CADL) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Candel Therapeutics Inc stocks. The insider ownership of Candel Therapeutics Inc is 25.21%, while institutional ownership is 36.97%. The most recent insider transaction that took place on Jul 28 ’25, was worth 6,540. In this transaction Chief Medical Officer of this company sold 937 shares at a rate of $6.98, taking the stock ownership to the 52,493 shares. Before that another transaction happened on Jun 30 ’25, when Company’s Chief Medical Officer sold 781 for $5.04, making the entire transaction worth $3,936. This insider now owns 52,493 shares in total.
Candel Therapeutics Inc (CADL) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.23 earnings per share (EPS) during the time that was better than consensus figure (set at -0.23) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.44% during the next five years compared to -43.86% drop over the previous five years of trading.
Candel Therapeutics Inc (NASDAQ: CADL) Trading Performance Indicators
You can see what Candel Therapeutics Inc (CADL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.56, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.01 in one year’s time.
